Management of left main disease: an update

Area of Science:

• Cardiology
• Interventional Cardiology
• Vascular Medicine

Background:

• Severe left main coronary artery (LMCA) narrowing, often from atherosclerosis, poses significant risks for major adverse cardiac events.
• Current management options for LMCA disease include coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI).
• PCI generally offers faster recovery and fewer early adverse events, while CABG provides a more durable outcome.

Purpose of the Study:

• To review current management strategies for LMCA disease.
• To emphasize clinical data and procedural insights supporting PCI for LMCA treatment.
• To highlight recent trial findings comparing PCI and CABG for LMCA disease.

Main Methods:

• Review of recent clinical trial data, specifically focusing on LMCA interventions.
• Analysis of contemporary PCI standards, including advanced stent technology, intravascular imaging, and physiological assessment.
• Synthesis of procedural knowledge to evaluate PCI's role in LMCA disease management.

Main Results:

• The largest LMCA trial demonstrated PCI non-inferiority to CABG for the composite endpoint of death, stroke, or myocardial infarction at 3 years in patients with low/intermediate anatomical complexity.
• This outcome was achieved using modern PCI techniques and technologies.
• PCI demonstrated comparable efficacy to CABG in this patient subgroup.

Conclusions:

• PCI is a viable and effective alternative to CABG for a growing number of patients with LMCA disease, particularly those with lower anatomical complexity.
• Advancements in PCI technology and techniques have enhanced its safety and efficacy.
• The findings support the increasing utilization of PCI in the management of LMCA disease.